(Image: Getty/Mohd Hafiez Mohd Razali / EyeEm)

WHO indicates preferred HIV treatment

By Vassia Barba

Citing evidence from two completed clinical trials, the WHO recommends dolutegravir as the preferred treatment for all patients with HIV.

(Image: Getty/Nito100)

J&J moves HIV vaccine into US and European trials

By Ben Hargreaves

J&J will test a vaccine candidate for HIV prevention in 3,800 men across the US and Europe, at the same time as ViiV releases positive comparative data on its HIV treatment.